Search Results
Results found for "GREGORY TALL"
- 📰 GPCR Weekly News, January 23 to 29, 2023
development of cachexia therapeutics Sosei Heptares Webinar Presentation for FY2022 Financial Results Call
- 📰 GPCR Weekly News, May 1 to 7, 2023
Industry News Addex Therapeutics to Release Q1 2023 Financial Results and Host Conference Call on May Beat Expectations, EPS Lags “As Precision Medicine is critical, we cannot think about one size fits all
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
orthosteric and allosteric interactions as interchangeable, you’re leaving precision (and money) on the table
- Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research
The donors act as light-harvesting antennas, capturing light from all directions, unlike the dipole-dipole This has been done in assays tracking IP1 and cAMP to detect biased agonism in GPCR ligands Table 1.
- 📰 GPCR Weekly News, January 16 to 22, 2023
Christopher Prior, as CEO and Reports Recent Drug Discovery Highlights Call for GPCR Papers GPCRs: Signal
- Why Opposing Processes Matter for Your Next GPCR Drug
Drug pipelines live and die by your ability to make fast, accurate calls. A renin inhibitor that lowers blood pressure in healthy volunteers might not drop blood pressure at all Reflexes as Drug Design Partners Not all reflexes are enemies. Some can make a mediocre drug shine. Ligands come and go, feedback loops kick in, and what you see in vitro rarely tells the whole story.
- 📰 GPCR Weekly News - January 9 to 15, 2023
collaborations GPCR Therapeutics Announces Launch of US Phase 2 Trial of GPC-100 in Multiple Myeloma Call
- 📰 GPCR Weekly News, July 17 to July 23, 2023
Premium members can always go back and watch the recorded talks at any time. Submit a 1-minute abstract video and tell us more about your project in this form.
- 📰 GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!
GPCR University offers two live courses this fall that you won’t want to miss.
- 📰 GPCR Weekly News, October 16 to 22, 2023
You can find more information about them on the Live Talks page and mark your calendar HERE.
- Quantifying Receptor Selectivity in Modern Drug Discovery
A compound shows no response in one assay, and we call it “selective.”
- Exploring the Breakthroughs in GPCR Research
interactions of the serotonin1A receptor Industry News Neurocrine Biosciences Announces Conference Call
- 📰 GPCR Weekly News, June 24 to 30, 2024
GPCR Ecosystem this fall.
- 📰 GPCR Weekly News, December 4 to 10, 2023
Nouvelle-Aquitaine Region Governor GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk
- 📰 GPCR Weekly News, February 13 to 19, 2023
Artificial Intelligence for Drug Discovery Call for GPCR Papers GPCRs: Signal Transduction.
- 📰 GPCR Weekly News, August 21 to 27, 2023
Submit poster abstracts via this form; short talks will be selected.
- 📰 GPCR Weekly News, February 6 to 12, 2023
Listing Rule 5635(c)(4) arcoscreen is one of the 13 biotech companies to discover in western in 2023 Call
- 📰 GPCR Weekly News, August 14 to 20, 2023
Submit poster abstracts using this form; short talks will be selected from submissions.
- 📰 GPCR Weekly News, April 3 to 9, 2023
The program is under construction but if you’d like to give a talk or present a poster, email us at Hello
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
With just one week left, becoming a premium member is all it takes to benefit from this discount! Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Call
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
The on-rate/off-rate balance matters: too tight, and penetration stalls; too loose, and efficacy dissipates Washout experiments don’t tell the full story.
- 📰 GPCR Weekly News, March 20 to 26, 2023
Call for GPCR Papers GPCRs: Signal Transduction. Ends tomorrow - March 31st, 2023.
- 📰 GPCR Weekly News, March 6 to 12, 2023
) Sosei Heptares Receives Approval for Change of Market Listing Segment to the Tokyo Stock Exchange Call
- 📰 GPCR Weekly News, January 8 to 14, 2024
The cost is $299 and includes: All 4 live Zoom sessions ( 4x 1 hour lecture + 30 mins Q&A) 30-minute GPCR Ecosystem contents and perks, including our forums, private groups, and all Ecosystem members Only Addiction Treatment AEF0117 GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk
- 📰 GPCR Weekly News, April 10 to 16, 2023
While the program is being finalized, if you're interested in giving a talk or presenting a poster, please
- 📰 GPCR Weekly News, January 1 to 7, 2024
The cost is $299 and includes: All 4 live Zoom sessions ( 4x 1 hour lecture + 30 mins Q&A) 30-minute GPCR Ecosystem contents and perks, including our forums, private groups, and all Ecosystem members Go crop protection company GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk
- FDA Approval Is a Strategy Obstacle, Not a Paperwork Problem
. 👉 Here’s what the FDA is actually optimizing for, and where most early-stage teams fall short: 1️⃣
- 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
G-Protein-Coupled Receptors Industry News Sosei Heptares to take back GPCR agonist after GSK changes course All-rounder In Parkinson’s Treatment GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk
- 📰 GPCR Weekly News, February 27 to March 5, 2023
Heptares and Neurocrine Biosciences won Top Out-Licensing Deal on the 8th annual Japan Deal of the Year Call
- 📰 GPCR Weekly News, November 20 to 26, 2023
Discovery and Development GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk










